Lyn Mateo

A randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE.

Niels H. Wulff, J. Vollmar, P. Chaplin, 2010, Vaccine.